173 related articles for article (PubMed ID: 18493655)
1. Bifunctional molecules evade cytochrome P(450) metabolism by forming protective complexes with FK506-binding protein.
Marinec PS; Lancia JK; Gestwicki JE
Mol Biosyst; 2008 Jun; 4(6):571-8. PubMed ID: 18493655
[TBL] [Abstract][Full Text] [Related]
2. FKBP family proteins: immunophilins with versatile biological functions.
Kang CB; Hong Y; Dhe-Paganon S; Yoon HS
Neurosignals; 2008; 16(4):318-25. PubMed ID: 18635947
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of calcineurin inhibition by complexes of immunosuppressive drugs with human FK506 binding proteins.
Weiwad M; Edlich F; Kilka S; Erdmann F; Jarczowski F; Dorn M; Moutty MC; Fischer G
Biochemistry; 2006 Dec; 45(51):15776-84. PubMed ID: 17176100
[TBL] [Abstract][Full Text] [Related]
4. Rescue of degradation-prone mutants of the FK506-rapamycin binding (FRB) protein with chemical ligands.
Stankunas K; Bayle JH; Havranek JJ; Wandless TJ; Baker D; Crabtree GR; Gestwicki JE
Chembiochem; 2007 Jul; 8(10):1162-9. PubMed ID: 17525916
[TBL] [Abstract][Full Text] [Related]
5. Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin.
Van Duyne GD; Standaert RF; Karplus PA; Schreiber SL; Clardy J
J Mol Biol; 1993 Jan; 229(1):105-24. PubMed ID: 7678431
[TBL] [Abstract][Full Text] [Related]
6. Rapid protein-ligand docking using soft modes from molecular dynamics simulations to account for protein deformability: binding of FK506 to FKBP.
Zacharias M
Proteins; 2004 Mar; 54(4):759-67. PubMed ID: 14997571
[TBL] [Abstract][Full Text] [Related]
7. The precise chemical-physical nature of the pharmacore in FK506 binding protein inhibition: ElteX, a New class of nanomolar FKBP12 ligands.
Martina MR; Tenori E; Bizzarri M; Menichetti S; Caminati G; Procacci P
J Med Chem; 2013 Feb; 56(3):1041-51. PubMed ID: 23301792
[TBL] [Abstract][Full Text] [Related]
8. A Plasmodium falciparum FK506-binding protein (FKBP) with peptidyl-prolyl cis-trans isomerase and chaperone activities.
Monaghan P; Bell A
Mol Biochem Parasitol; 2005 Feb; 139(2):185-95. PubMed ID: 15664653
[TBL] [Abstract][Full Text] [Related]
9. The FKBP-associated protein FAP48 is an antiproliferative molecule and a player in T cell activation that increases IL2 synthesis.
Krummrei U; Baulieu EE; Chambraud B
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2444-9. PubMed ID: 12604780
[TBL] [Abstract][Full Text] [Related]
10. Selective ligand purification using high-performance affinity beads.
Ohtsu Y; Ohba R; Imamura Y; Kobayashi M; Hatori H; Zenkoh T; Hatakeyama M; Manabe T; Hino M; Yamaguchi Y; Kataoka K; Kawaguchi H; Watanabe H; Handa H
Anal Biochem; 2005 Mar; 338(2):245-52. PubMed ID: 15745744
[TBL] [Abstract][Full Text] [Related]
11. Peptidyl-prolyl isomerase inhibitors.
Wang XJ; Etzkorn FA
Biopolymers; 2006; 84(2):125-46. PubMed ID: 16302169
[TBL] [Abstract][Full Text] [Related]
12. FK506-binding protein ligands: structure-based design, synthesis, and neurotrophic/neuroprotective properties of substituted 5,5-dimethyl-2-(4-thiazolidine)carboxylates.
Zhao L; Huang W; Liu H; Wang L; Zhong W; Xiao J; Hu Y; Li S
J Med Chem; 2006 Jul; 49(14):4059-71. PubMed ID: 16821768
[TBL] [Abstract][Full Text] [Related]
13. Exploration of pipecolate sulfonamides as binders of the FK506-binding proteins 51 and 52.
Gopalakrishnan R; Kozany C; Wang Y; Schneider S; Hoogeland B; Bracher A; Hausch F
J Med Chem; 2012 May; 55(9):4123-31. PubMed ID: 22455398
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of PMF scoring in docking weak ligands to the FK506 binding protein.
Muegge I; Martin YC; Hajduk PJ; Fesik SW
J Med Chem; 1999 Jul; 42(14):2498-503. PubMed ID: 10411471
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the FKBP.rapamycin.FRB ternary complex.
Banaszynski LA; Liu CW; Wandless TJ
J Am Chem Soc; 2005 Apr; 127(13):4715-21. PubMed ID: 15796538
[TBL] [Abstract][Full Text] [Related]
16. Non-FK506-binding protein-12 neuroimmunophilin ligands increase neurite elongation and accelerate nerve regeneration.
Gold BG; Armistead DM; Wang MS
J Neurosci Res; 2005 Apr; 80(1):56-65. PubMed ID: 15732051
[TBL] [Abstract][Full Text] [Related]
17. Detection of the FK506-FKBP-calcineurin complex by a simple binding assay.
Asami M; Kuno T; Mukai H; Tanaka C
Biochem Biophys Res Commun; 1993 May; 192(3):1388-94. PubMed ID: 7685169
[TBL] [Abstract][Full Text] [Related]
18. Increased striatal mRNA and protein levels of the immunophilin FKBP-12 in experimental Parkinson's disease and identification of FKBP-12-binding proteins.
Nilsson A; Sköld K; Sjögren B; Svensson M; Pierson J; Zhang X; Caprioli RM; Buijs J; Persson B; Svenningsson P; Andrén PE
J Proteome Res; 2007 Oct; 6(10):3952-61. PubMed ID: 17877381
[TBL] [Abstract][Full Text] [Related]
19. Differential responses of the backbone and side-chain conformational dynamics in FKBP12 upon binding the transition-state analog FK506: implications for transition-state stabilization and target protein recognition.
Brath U; Akke M
J Mol Biol; 2009 Mar; 387(1):233-44. PubMed ID: 19361439
[TBL] [Abstract][Full Text] [Related]
20. A ligand-reversible dimerization system for controlling protein-protein interactions.
Rollins CT; Rivera VM; Woolfson DN; Keenan T; Hatada M; Adams SE; Andrade LJ; Yaeger D; van Schravendijk MR; Holt DA; Gilman M; Clackson T
Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7096-101. PubMed ID: 10852943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
